166 related articles for article (PubMed ID: 24606575)
1. Case of uterine papillary serous carcinoma following tamoxifen treatment that could not be diagnosed during screening.
Maenaka T; Egawa-Takata T; Hisamoto K; Kunishige I; Nishio Y; Tsujimoto M
J Obstet Gynaecol Res; 2014 May; 40(5):1450-4. PubMed ID: 24606575
[TBL] [Abstract][Full Text] [Related]
2. Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinoma.
Pierce SR; Stine JE; Gehrig PA; Havrilesky LJ; Secord AA; Nakayama J; Snavely AC; Moore DT; Kim KH
Gynecol Oncol; 2017 Mar; 144(3):531-535. PubMed ID: 28062116
[TBL] [Abstract][Full Text] [Related]
3. Serous endometrial intraepithelial carcinoma: a case report.
Najioui Y; Karich N; Haloui A; Miry A; Bennani A
Pan Afr Med J; 2023; 44():122. PubMed ID: 37275288
[TBL] [Abstract][Full Text] [Related]
4. Synchronous metastasis from lobular carcinoma and primary carcinoma of the endometrium in a patient after tamoxifen therapy.
Vicioso L; Ortega MV; Cívico V; López-Beltrán A
Int J Gynecol Pathol; 2013 Jan; 32(1):66-70. PubMed ID: 23202785
[TBL] [Abstract][Full Text] [Related]
5. Cytologic findings of cervicovaginal smears in women with uterine papillary serous carcinoma.
Park JY; Kim HS; Hong SR; Chun YK
J Korean Med Sci; 2005 Feb; 20(1):93-7. PubMed ID: 15716611
[TBL] [Abstract][Full Text] [Related]
6. Difficult Diagnosis of Peritoneal Serous Papillary Carcinoma in a 63-year-old Woman: A Case Report.
Tsuda B; Kajiwara H; Sakota N; Amatsu S; Tanaka A; Ikeda M
Tokai J Exp Clin Med; 2019 Sep; 44(3):49-53. PubMed ID: 31448396
[TBL] [Abstract][Full Text] [Related]
7. Metastatic uterine serous carcinoma originating in an endometrial polyp: a report of 2 cases.
Childs AJ; Burke JJ; Perry MY; Gallup DG
J Reprod Med; 2005 Mar; 50(3):209-12. PubMed ID: 15841935
[TBL] [Abstract][Full Text] [Related]
8. Papillary serous carcinoma of the ovary following prolonged tamoxifen treatment.
Seoud M; Salem Z; Shamseddine A; Khabbaz A; Zaatari G; Khalil A
Eur J Gynaecol Oncol; 1999; 20(3):237-9. PubMed ID: 10410898
[TBL] [Abstract][Full Text] [Related]
9. Papillary serous carcinoma of peritoneum: case study and review of the literature on the differential diagnosis of malignant peritoneal tumors.
Koutselini HA; Lazaris AC; Thomopoulou G; Papayannopoulou A; Kairi-Vasilatou E
Adv Clin Path; 2001 Jul; 5(3):99-104. PubMed ID: 11753882
[TBL] [Abstract][Full Text] [Related]
10. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
Kelly MG; O'malley DM; Hui P; McAlpine J; Yu H; Rutherford TJ; Azodi M; Schwartz PE
Gynecol Oncol; 2005 Sep; 98(3):353-9. PubMed ID: 16005947
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy in uterine papillary serous carcinoma.
Resnik E; Taxy JB
Gynecol Oncol; 1996 Jul; 62(1):123-7. PubMed ID: 8690284
[TBL] [Abstract][Full Text] [Related]
12. Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy.
Chang-Halpenny CN; Natarajan S; Hwang-Graziano J
Gynecol Oncol; 2013 Dec; 131(3):598-603. PubMed ID: 24135679
[TBL] [Abstract][Full Text] [Related]
13. A case of serous endometrial intraepithelial carcinoma with p53 positivity for six years.
Kaku S; Moriya T; Ushioda N; Nakai Y; Shimoya K; Nakamura T
J Obstet Gynaecol Res; 2012 Feb; 38(2):455-60. PubMed ID: 22176439
[TBL] [Abstract][Full Text] [Related]
14. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy.
McCluggage WG; Sumathi VP; McManus DT
Hum Pathol; 2003 Sep; 34(9):939-43. PubMed ID: 14562291
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
Hoogendoorn WE; Hollema H; van Boven HH; Bergman E; de Leeuw-Mantel G; Platteel I; Fles R; Nederlof PM; Mourits MJ; van Leeuwen FE;
Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
[TBL] [Abstract][Full Text] [Related]
16. Uterine papillary serous carcinoma in a 32-year-old with Turner's syndrome.
Woolas RP; Williams K; McCartney AJ
Gynecol Oncol; 1994 Mar; 52(3):395-401. PubMed ID: 8157198
[TBL] [Abstract][Full Text] [Related]
17. HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.
McCluggage WG; Connolly LE; McBride HA; Kalloger S; Gilks CB
Histopathology; 2012 Mar; 60(4):547-53. PubMed ID: 22250726
[TBL] [Abstract][Full Text] [Related]
18. Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen.
Lee LJ; Demaria R; Berkowitz R; Matulonis U; Viswanathan AN
Gynecol Oncol; 2014 Jan; 132(1):65-9. PubMed ID: 24211401
[TBL] [Abstract][Full Text] [Related]
19. Papillary serous carcinoma arising from adenomyosis presenting as intramural leiomyoma.
Izadi-Mood N; Samadi N; Sarmadi S; Eftekhar Z
Arch Iran Med; 2007 Apr; 10(2):258-60. PubMed ID: 17367236
[TBL] [Abstract][Full Text] [Related]
20. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
